111 related articles for article (PubMed ID: 1651589)
1. Complementation of adenovirus early region 1a and 2a mutants by Epstein-Barr virus immortalized lymphoblastoid cell lines.
Horvath J; Faxing C; Weber JM
Virology; 1991 Sep; 184(1):141-8. PubMed ID: 1651589
[TBL] [Abstract][Full Text] [Related]
2. Cloning of the herpes simplex virus ICP4 gene in an adenovirus vector: effects on adenovirus gene expression and replication.
Spessot R; Inchley K; Hupel TM; Bacchetti S
Virology; 1989 Feb; 168(2):378-87. PubMed ID: 2536987
[TBL] [Abstract][Full Text] [Related]
3. Maintenance of cellular proliferation by adenovirus early region 1A in fibroblasts conditionally immortalized by using simian virus 40 large T antigen requires conserved region 1.
Riley TE; Follin A; Jones NC; Jat PS
Mol Cell Biol; 1990 Dec; 10(12):6664-73. PubMed ID: 2174113
[TBL] [Abstract][Full Text] [Related]
4. Virus-associated RNA I-deleted adenovirus, a potential oncolytic agent targeting EBV-associated tumors.
Wang Y; Xue SA; Hallden G; Francis J; Yuan M; Griffin BE; Lemoine NR
Cancer Res; 2005 Feb; 65(4):1523-31. PubMed ID: 15735041
[TBL] [Abstract][Full Text] [Related]
5. The transforming prototype of Epstein-Barr virus (B95-8) is also a lytic virus.
Glaser R; Tarr KL; Dangel AW
Int J Cancer; 1989 Jul; 44(1):95-100. PubMed ID: 2545637
[TBL] [Abstract][Full Text] [Related]
6. An E1A mutant of adenovirus type 3: Ad3hr15 has reiterated DNA sequences 5' to its E1A gene.
Larsen PL; McGrane MM; Robinson CC; Tibbetts C
Virology; 1986 Nov; 155(1):148-59. PubMed ID: 3022466
[TBL] [Abstract][Full Text] [Related]
7. Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants.
Krougliak V; Graham FL
Hum Gene Ther; 1995 Dec; 6(12):1575-86. PubMed ID: 8664382
[TBL] [Abstract][Full Text] [Related]
8. Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectors.
Imler JL; Chartier C; Dreyer D; Dieterle A; Sainte-Marie M; Faure T; Pavirani A; Mehtali M
Gene Ther; 1996 Jan; 3(1):75-84. PubMed ID: 8929914
[TBL] [Abstract][Full Text] [Related]
9. The interaction of non-transforming Epstein-Barr virus (EBV) with cell-associated EBV DNA in superinfected lymphoblastoid cell lines.
Stoerker J; Yajima Y; Glaser R
Int J Cancer; 1982 Oct; 30(4):385-92. PubMed ID: 6292115
[TBL] [Abstract][Full Text] [Related]
10. Repression of adenovirus early gene expression by coinfection with a temperature-sensitive mutant in the immediate-early gene of pseudorabies virus.
Feldman LT; Ahlers SE
J Virol; 1986 Jan; 57(1):13-7. PubMed ID: 3001339
[TBL] [Abstract][Full Text] [Related]
11. Construction and analysis of additional adenovirus substitution mutants confirm the complementation of VAI RNA function by two small RNAs encoded by Epstein-Barr virus.
Bhat RA; Thimmappaya B
J Virol; 1985 Dec; 56(3):750-6. PubMed ID: 2999431
[TBL] [Abstract][Full Text] [Related]
12. Use of adenovirus vectors expressing Epstein-Barr virus (EBV) immediate-early protein BZLF1 or BRLF1 to treat EBV-positive tumors.
Feng WH; Westphal E; Mauser A; Raab-Traub N; Gulley ML; Busson P; Kenney SC
J Virol; 2002 Nov; 76(21):10951-9. PubMed ID: 12368338
[TBL] [Abstract][Full Text] [Related]
13. [The viral genome status studied under the conditions of a mixed infection in lymphoblastoid cells by adenovirus and the Epstein-Barr virus].
Nosach LN; Diachenko NS; Povnitsa OIu; Smirnova IA; Kishinskaia EG; Butenko ZA; Panasenko GV
Tsitol Genet; 1998; 32(4):82-8. PubMed ID: 9813890
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle.
Gradoville L; Kwa D; El-Guindy A; Miller G
J Virol; 2002 Jun; 76(11):5612-26. PubMed ID: 11991990
[TBL] [Abstract][Full Text] [Related]
15. An adenovirus type 3 host range variant with mutations in the E1a and E3 early gene regions.
McDougall I; Mautner V
J Gen Virol; 1987 May; 68 ( Pt 5)():1361-71. PubMed ID: 2883250
[TBL] [Abstract][Full Text] [Related]
16. Efficient Translation of Epstein-Barr Virus (EBV) DNA Polymerase Contributes to the Enhanced Lytic Replication Phenotype of M81 EBV.
Church TM; Verma D; Thompson J; Swaminathan S
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263273
[TBL] [Abstract][Full Text] [Related]
17. Determining the role of the Epstein-Barr virus Cp EBNA2-dependent enhancer during the establishment of latency by using mutant and wild-type viruses recovered from cottontop marmoset lymphoblastoid cell lines.
Yoo L; Speck SH
J Virol; 2000 Dec; 74(23):11115-20. PubMed ID: 11070007
[TBL] [Abstract][Full Text] [Related]
18. Immortalization of human T lymphocytes after transfection of Epstein-Barr virus DNA.
Stevenson M; Volsky B; Hedenskog M; Volsky DJ
Science; 1986 Aug; 233(4767):980-4. PubMed ID: 3016899
[TBL] [Abstract][Full Text] [Related]
19. Growth arrest of Epstein-Barr virus immortalized B lymphocytes by adenovirus-delivered ribozymes.
Huang S; Stupack D; Mathias P; Wang Y; Nemerow G
Proc Natl Acad Sci U S A; 1997 Jul; 94(15):8156-61. PubMed ID: 9223331
[TBL] [Abstract][Full Text] [Related]
20. Clonality and methylation status of the Epstein-Barr virus (EBV) genomes in in vivo-infected EBV-carrying chronic lymphocytic leukemia (CLL) cell lines.
Lewin N; Minarovits J; Weber G; Ehlin-Henriksson B; Wen T; Mellstedt H; Klein G; Klein E
Int J Cancer; 1991 Apr; 48(1):62-6. PubMed ID: 1850384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
